Important Risk Warning:
  • The mention of any investment product should not be construed as representing a recommendation to buy or sell that product, nor does it represent a forecast on future performance of the product.
  • Unit Trusts are investment products and some may involve derivatives. The value of investments and units may go down and up, and the investor may not get back the original sum invested. Past performance is not necessarily indicative of future performance. In a worst case scenario, the value of the fund may worth substantially less than the original amount you have invested (and in an extreme case could be worth nothing).
  • Investors and potential investors must not solely rely on the content in this website to make investment decisions and should read carefully and understand the offering documents (including the prospectus and full text of the risk factors stated therein), available at HSBC branches and at the fundhouses' webpages, before investing.
  • Before you make any investment decision, you may wish to consult a financial adviser. In the event that you choose not to seek advice from a financial adviser, you should carefully consider whether the investment product is suitable for you.
Selecting products with risk level relative to your attitude towards investment risk.
At HSBC, we offer a full range of products for your consideration with respect to your investment objective, investment tenor and your attitude according to the table below.
The Fund Risk Level stated in this website is determined according to the historical volatility of the fund or, where appropriate, the historical volatility of a comparable market index or comparable fund:
Risk attitude Funds with risk level commensurate
Secure Risk Level 0
Very Cautious Risk Level 1
Cautious Risk Level 1 – 2
Balanced Risk Level 1 – 3
Adventurous Risk Level 1 – 4
Speculative Risk Level 1 – 5
Quick Search
Advanced Search
Top Performers
New Funds
Promotion Offer

 
     
HSBC Global Fund Approvals and Research List  Top Performers  CPFIS/SRS  MIP 
Factsheet  Chinese Factsheet  Prospectus  Annual Report  Interim Report  Product highlight sheet 
Fund Code: HSHCU
HGIF Global Equity Sustainable Healthcare AC USD       
Risk Level: 5
Offering Document: 
 
Investment Objective
The sub-fund aims to provide long term total return by investing in a portfolio of equities of companies that may benefit from increasingly constrained healthcare budgets world-wide. The sub-fund aims to do this by investing in companies with revenue exposure to innovative sustainable healthcare themes and products which have the potential to improve value for money of healthcare spending (“Sustainable Healthcare Themes and Products”). The sub-fund’s aims are aligned with goal three of the UN Sustainable Development Goals, which is a social goal focused on good health and well-being. The sub-fund will invest a minimum of 80% of its net assets in equities and equity equivalent securities of companies with at least two thirds of their revenues derived from Sustainable Healthcare Themes and Products, which are domiciled in, based in, carry out business activities in, or are listed on a Regulated Market in, any country including both developed and Emerging Markets.
Investment Strategy
HSBC investment category:
Healthcare
Investment type:
Equity
Investment style:
Equity
Interest rate sensitivity:
-
Investment instrument:
Stock, Cash, Other
Investment style is only applicable for funds that invest in equities. Interest rate sensitivity is only applicable for funds that invest in fixed income product.
Fund Portfolio
(as of 31-08-2021)
Asset allocation
Stock
Bond
Cash
Other
97.65%
0.00%
1.13%
1.22%
Total number of equity holdings: 41
Total number of bond holdings : 0
Equity holdings geographical allocation
Equity holdings sector allocation
Top 10 holdings
Holding % of net asset
Regeneron Pharmaceuticals Inc 3.78
Top 10 underlying holdings
% of asset in Top 10 holdings -
Teleflex Inc 3.51
Top 10 underlying holdings
% of asset in Top 10 holdings -
Inspire Medical Systems Inc 3.46
Top 10 underlying holdings
% of asset in Top 10 holdings -
Biohaven Pharmaceutical Holding Co Ltd 3.43
Top 10 underlying holdings
% of asset in Top 10 holdings -
PTC Therapeutics Inc 3.43
Top 10 underlying holdings
% of asset in Top 10 holdings -
Abiomed Inc 3.42
Top 10 underlying holdings
% of asset in Top 10 holdings -
Neurocrine Biosciences Inc 3.36
Top 10 underlying holdings
% of asset in Top 10 holdings -
Axonics Inc 3.19
Top 10 underlying holdings
% of asset in Top 10 holdings -
Halozyme Therapeutics Inc 3.15
Top 10 underlying holdings
% of asset in Top 10 holdings -
Exact Sciences Corp 3.12
Top 10 underlying holdings
% of asset in Top 10 holdings -
% of asset in Top 10 holdings 33.86
Fund Performance
(as of 30-09-2021)
Fund: HGIF Global Equity Sustainable Healthcare AC USD
Index:
Fund performance is not calculated for fund which has less than 6 months history.
Fund Price Information
(as of 21-10-2021)
Fund price is not calculated for fund which has less than 6 months history
Indicative fund price:
  • NAV:
USD 10.99
  • Bid:
-
  • Offer:
-
Change vs previous trading day:
0.39%
52 week low-high:
USD 10.529 - USD 11.546
Fund price information is provided based on the latest fund trading date.
Fund Statistic
(as of 30-09-2021)
Annualised return:
-
Standard deviation:
-
Sharpe ratio:
-
Alpha:
-
Beta:
-
Fund statistics are calculated by using 3 years historical data, and are not calculated for fund which is less than 3 years old.
Fees and Charges
Initial charge:
0.03
Annual management fee (maximum):
0.015
Distribution fee:
-
Redemption fee:
0
Performance fee:
-
Highest contingent deferred sales charge:
-
Switching Fee:
-
The listed information may not cover all the fees and charges imposed on a fund. Please refer to the respective offering documents of the fund for details of relevant fees and charges.
Other Fund Information
Fund class currency:
USD
Fund class inception date:
28-07-2021
Fund share class size (Million):
USD 2.24
(as of 30-09-2021)
Fund manager
(Start date):
Michael Schroter (28-06-2021)
Nathalie Flury (28-06-2021)
Fund house:
-
Morningstar Rating:

ISIN:
LU2324357040
Initial Investment Amount:
1000
Other fund classes available with HSBC:
Back to top    


Disclaimers:


The declaration of distribution is at the sole discretion of the Fund Manager and is not guaranteed. The dividend information is for your reference only and it is not indicative of future performance.

The information in this website relating to Unit Trusts are provided by Morningstar Asia Limited (“Information Provider”) to HSBC Bank (Singapore) Limited (the “Bank”) unless otherwise specified. For technical reasons, certain information provided by Information Provider may be different from that supplied by the respective fund houses. Neither the Information Provider nor the Bank guarantee or endorse the accuracy, reliability and completeness of the information provided by the Information Provider or that it is up-to date, and that such information has not been independently verified by the Bank. The Bank disclaims liability for any errors, omissions or inaccuracies in the information provided in this website. The Bank also disclaims liability for any loss or damages resulting from the use of information contained herein, or the inability to use such information or in connection with any error, interruption, delay in operation or incomplete transmission, line or system failure. The information contained herein is solely for personal and non-commercial use and for reference only, and the information are not intended to provide professional advice nor is HSBC, in providing such information intended to be advising on Unit Trust. The information contained in this website is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribed for any Unit Trusts or other investments or products or deposit. The information contain herein may not be copied or re-distributed by any means.


Investment involves risk. Investments are not obligations of, deposits in, insured or guaranteed by HSBC Bank (Singapore) Limited. The information contained on this web site is intended for Singapore residents only and should not be construed as a distribution, an offer to sell, or a solicitation to buy any securities in any jurisdiction where such activities would be unlawful under the laws of such jurisdiction, in particular the United States of America and Canada. You should refer to the website disclaimers for further important details.


The Fund Risk Level stated in this website is determined according to the historical volatility of the fund or, where appropriate, the historical volatility of a comparable market index or comparable fund. You should refer to the detailed definition of fund risk level here.


  [Disclaimer]